Nanalysis Scientific Corp.
NSCIF
$0.2215
$0.01175.58%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 64.79% | 51.54% | 43.15% | 10.80% | 8.04% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 64.79% | 51.54% | 43.15% | 10.80% | 8.04% |
| Cost of Revenue | 44.83% | 44.45% | 68.77% | 67.88% | 108.24% |
| Gross Profit | 193.81% | 82.59% | -14.85% | -64.22% | -73.71% |
| SG&A Expenses | -17.33% | -18.63% | -21.39% | -17.19% | -3.15% |
| Depreciation & Amortization | -6.77% | -7.88% | -8.11% | -6.86% | 10.04% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.31% | 13.64% | 17.49% | 16.78% | 36.27% |
| Operating Income | 63.45% | 50.90% | 27.02% | -31.71% | -138.98% |
| Income Before Tax | 63.17% | 23.01% | -2.84% | -57.35% | -155.77% |
| Income Tax Expenses | 157.87% | 164.13% | 148.27% | 95.79% | -3,587.35% |
| Earnings from Continuing Operations | 54.26% | 9.90% | -16.07% | -64.40% | -135.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -100.00% | -100.00% | -80.56% | -29.35% | 128.21% |
| Net Income | 51.60% | 2.23% | -25.50% | -72.70% | -135.60% |
| EBIT | 63.45% | 50.90% | 27.02% | -31.71% | -138.98% |
| EBITDA | 58.52% | 49.20% | 25.10% | -54.94% | -313.94% |
| EPS Basic | 55.53% | 9.48% | -16.94% | -61.82% | -118.00% |
| Normalized Basic EPS | 50.99% | 33.94% | 11.00% | -40.13% | -115.24% |
| EPS Diluted | 51.51% | 11.29% | -14.54% | -51.93% | -97.41% |
| Normalized Diluted EPS | 50.99% | 33.94% | 11.00% | -40.13% | -115.24% |
| Average Basic Shares Outstanding | 10.65% | 9.68% | 7.49% | 7.25% | 10.44% |
| Average Diluted Shares Outstanding | 10.65% | 9.68% | 7.49% | 7.25% | 10.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |